Has Itshac Ben-Dor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $393,370 in general payments to Itshac Ben-Dor, MD across 1,059 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Itshac Ben-Dor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Itshac Ben-Dor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Itshac Ben-Dor, MD

Interventional Cardiology · Washington, DCNPI 1932356961

Payments from drug & device makers

$393,370in general payments, 2019–2025

Across 1,059 payments — averaging $371.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

M.a. Med Alliance S.A.$152K
Biotronik Inc.$150K
Medalliance LLC$29K
Essential Medical, Inc.$27K
Bayer$9K
Boston Scientific$4K
plus $21K from 36 others

What the payments were for

Consulting fees$4,90019%
Travel & lodging$4,30017%
Food & beverage$16,17463%
Education$990%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
M.a. Med Alliance S.A.	11	$151,805
Biotronik Inc.	654	$150,281
Medalliance LLC	4	$29,382
Essential Medical, Inc.	1	$27,241
Bayer	11	$9,336
Boston Scientific	50	$4,376
Medtronic(2 entities)	70	$4,027
Abbott	43	$3,827
Cordis US CORP.	1	$2,400
Cathworks, Inc.	1	$1,500
Ancora Heart, Inc.	6	$1,469
Teleflex LLC	10	$981
Amgen	29	$844
AstraZeneca	37	$782
Arrow International, Inc.	1	$650
Terumo Medical Corporation	5	$440
Abiomed	9	$409
Edwards Lifesciences	7	$360
E.r. Squibb & Sons, L.L.C.	12	$322
Cardiovascular Systems Inc.	6	$314
Pfizer	17	$311
Johnson & Johnson	18	$299
Novo Nordisk	10	$242
Jenavalve Technology, Inc.	1	$238
Asahi Intecc USA, Inc.	7	$219
Cook Medical LLC	3	$206
Chiesi USA, Inc.	4	$173
Shockwave Medical, Inc	4	$152
Penumbra, Inc.	1	$150
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	8	$125
Novartis	5	$119
Siemens Medical Solutions USA, Inc.	1	$88
Cardiva Medical, Inc.	2	$53
Celonova Biosciences, Inc.	1	$49
Recor Medical Inc	2	$43
Cardinal Health 200 LLC	1	$37
Kestra Medical Technology Services, Inc.	1	$27
Bard Peripheral Vascular, Inc.	1	$26
Atricure, Inc.	1	$20
Silk Road Medical, Inc.	1	$18
W. L. Gore & Associates, Inc.	1	$15
Toray International America Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$378,306

Medicare patients

658

Services billed

1,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	90	$1,085
Metoprolol Succinate	40	$694
Furosemide	37	$140
Atorvastatin Calcium	14	$106
Prednisone	13	$25

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Washington

Ron WaksmanWashington$24.1M
Lowell SatlerWashington$2.3M
Nelson BernardoWashington$1.2M
Toby RogersWashington$978K
Augusto PichardWashington$182K
Jonathan ReinerWashington$159K
Horst SievertWashington$66K
Brian CaseWashington$63K
Ramesh MazhariWashington$41K
Nardos TemesgenWashington$8K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →